Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000
1030.HK Stock Summary
Top 10 Correlated ETFs
1030.HK
In the News
1030.HK Financial details
Company Rating
Buy
Market Cap
7.18B
Income
7.39B
Revenue
248.81B
Book val./share
6.48
Cash/share
3.1
Dividend
-
Dividend %
-
Employees
24.29K
Optionable
No
Shortable
Yes
Earnings
28 Mar 2024
P/E
8.81
Forward P/E
3.31
PEG
-5.57
P/S
0.06
P/B
0.15
P/C
0.34
P/FCF
1.23
Quick Ratio
0.08
Current Ratio
0.96
Debt / Equity
1.61
LT Debt / Equity
0.52
-
-
EPS (TTM)
1.17
EPS next Y
0.32
EPS next Q
-
EPS this Y
-96.89%
EPS next Y
-72.81%
EPS next 5Y
-72.81%
EPS last 5Y
-47.76%
Revenue last 5Y
16.3%
Revenue Q/Q
-41.89%
EPS Q/Q
-186.96%
-
-
-
-
SMA20
-7.89%
SMA50
-3.67%
SMA100
-17.97%
Inst Own
-
Inst Trans
-
ROA
-
ROE
2%
ROC
0.04%
Gross Margin
14%
Oper. Margin
5%
Profit Margin
1%
Payout
-
Shs Outstand
7.04B
Shs Float
2.45B
-
-
-
-
Target Price
-
52W Range
0.94-2.23
52W High
-
52W Low
-
RSI
47.59
Rel Volume
0.38
Avg Volume
23.92M
Volume
9.03M
Perf Week
0.95%
Perf Month
3.92%
Perf Quarter
-22.63%
Perf Half Y
-26.39%
-
-
-
-
Beta
2.098
-
-
Volatility
0.02%, 0.04%
Prev Close
2.91%
Price
1.06
Change
0.95%
1030.HK Financial Performance
Yearly Fundamentals Overview
Last date of statement is 2022-12-31
Metric | History | 2018-12-31 | 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 8.97 | 14.72 | 23.62 | 27.4 | 17.96 | |
Net income per share | 1.11 | 1.32 | 1.65 | 1.39 | 0.04 | |
Operating cash flow per share | 0.05 | 6.38 | -1.07 | 2.52 | 1.15 | |
Free cash flow per share | -0.03 | 6.29 | -1.27 | 2.28 | 0.97 | |
Cash per share | 6.78 | 10.18 | 9.77 | 7.73 | 3.63 | |
Book value per share | 3.13 | 4.24 | 5.78 | 6.81 | 6.9 | |
Tangible book value per share | 7.32 | 9.72 | 13.1 | 15.67 | 14.27 | |
Share holders equity per share | 3.13 | 4.24 | 5.78 | 6.81 | 6.9 | |
Interest debt per share | 13.43 | 15.19 | 17.19 | 17.08 | 12.61 | |
Market cap | 28.74B | 49.93B | 33.68B | 26.61B | 16.56B | |
Enterprise value | 69.03B | 78.29B | 80.12B | 84.94B | 73.63B | |
P/E ratio | 4.25 | 6.39 | 3.31 | 3.1 | 59.02 | |
Price to sales ratio | 0.52 | 0.57 | 0.23 | 0.16 | 0.14 | |
POCF ratio | 89.54 | 1.33 | -5.08 | 1.71 | 2.22 | |
PFCF ratio | -160.37 | 1.35 | -4.3 | 1.88 | 2.63 | |
P/B Ratio | 1.5 | 2 | 0.94 | 0.63 | 0.37 | |
PTB ratio | 1.5 | 2 | 0.94 | 0.63 | 0.37 | |
EV to sales | 1.26 | 0.9 | 0.55 | 0.5 | 0.63 | |
Enterprise value over EBITDA | 4.72 | 4.14 | 3.6 | 4.75 | 12.67 | |
EV to operating cash flow | 215.07 | 2.08 | -12.09 | 5.45 | 9.86 | |
EV to free cash flow | -385.21 | 2.11 | -10.23 | 6.01 | 11.67 | |
Earnings yield | 0.24 | 0.16 | 0.3 | 0.32 | 0.02 | |
Free cash flow yield | -0.01 | 0.74 | -0.23 | 0.53 | 0.38 | |
Debt to equity | 4.26 | 3.52 | 2.93 | 2.47 | 1.76 | |
Debt to assets | 0.24 | 0.19 | 0.19 | 0.19 | 0.17 | |
Net debt to EBITDA | 2.76 | 1.5 | 2.09 | 3.26 | 9.82 | |
Current ratio | 1.16 | 1.03 | 1.1 | 1.06 | 0.96 | |
Interest coverage | 26.51 | 11.57 | 13.24 | 12.42 | 1.77 | |
Income quality | 0.05 | 4.82 | -0.65 | 1.82 | 26.6 | |
Dividend Yield | 0.03 | 0.04 | 0.06 | 0.1 | 3.12 | |
Payout ratio | 0.14 | 0.23 | 0.19 | 0.3 | 184.01 | |
Sales general and administrative to revenue | 0.05 | 0.05 | 0.03 | 0.03 | 0.04 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | -1.56 | -0.02 | 0.18 | -0.09 | -0.15 | |
Capex to revenue | -0.01 | -0.01 | -0.01 | -0.01 | -0.01 | |
Capex to depreciation | -1.18 | -0.86 | -1.38 | -1.76 | -1.85 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 8.83 | 11.24 | 14.63 | 14.59 | 2.59 | |
ROIC | 0.09 | 0.09 | 0.09 | 0.07 | 0.01 | |
Return on tangible assets | 0.02 | 0.02 | 0.02 | 0.02 | 0 | |
Graham Net | -21.72 | -30.79 | -34.68 | -34.24 | -30.59 | |
Working capital | 36.62B | 12.38B | 38.59B | 23.5B | -11.9B | |
Tangible asset value | 44.74B | 57.33B | 81.05B | 96.98B | 92.65B | |
Net current asset value | -23.76B | -39.16B | -41.2B | -49.8B | -64.09B | |
Invested capital | 4.26 | 3.52 | 2.93 | 2.47 | 1.76 | |
Average receivables | 29.51B | 64.83B | 70.53B | 73.72B | 69.32B | |
Average payables | 33.35B | 42.58B | 49.72B | 59.36B | 55.45B | |
Average inventory | 111B | 188.44B | 250.95B | 260.5B | 227.4B | |
Days sales outstanding | 392.49 | 297.37 | 175.63 | 166.05 | 192.67 | |
Days payables outstanding | 454.84 | 249.13 | 188.04 | 157.73 | 186.15 | |
Days of inventory on hand | 1.5K | 1.4K | 871.55 | 654.61 | 752.35 | |
Receivables turnover | 0.93 | 1.23 | 2.08 | 2.2 | 1.89 | |
Payables turnover | 0.8 | 1.47 | 1.94 | 2.31 | 1.96 | |
Inventory turnover | 0.24 | 0.26 | 0.42 | 0.56 | 0.49 | |
ROE | 0.35 | 0.31 | 0.28 | 0.2 | 0.01 | |
Capex per share | -0.08 | -0.1 | -0.2 | -0.24 | -0.18 |
Quarterly Fundamentals Overview
Last date of statement is 2023-06-30 for Q2
Metric | History | 2021-06-30 | 2021-12-31 | 2022-06-30 | 2022-12-31 | 2023-06-30 |
---|---|---|---|---|---|---|
2.02K | 2.02K | 2.02K | 2.02K | 2.02K | ||
Revenue per share | 12.9 | 14.49 | 6.73 | 11.19 | 6.02 | |
Net income per share | 0.47 | 0.92 | 0.28 | -0.23 | 0.2 | |
Operating cash flow per share | -1.27 | 3.79 | 1.77 | -0.61 | 0.82 | |
Free cash flow per share | -1.34 | 3.62 | 1.61 | -0.62 | 0.79 | |
Cash per share | 8.82 | 7.72 | 6.2 | 3.61 | 3.1 | |
Book value per share | 5.88 | 6.81 | 6.94 | 6.84 | 6.48 | |
Tangible book value per share | 14.15 | 15.67 | 15.17 | 14.17 | 13.12 | |
Share holders equity per share | 5.88 | 6.81 | 6.94 | 6.84 | 6.48 | |
Interest debt per share | 18.52 | 16.85 | 14.41 | 12.07 | 10.42 | |
Market cap | 37.9B | 26.63B | 21.33B | 16.69B | 9.99B | |
Enterprise value | 99.96B | 84.95B | 76.05B | 73.76B | 63.52B | |
P/E ratio | 3.25 | 1.17 | 2.98 | -2.77 | 1.75 | |
Price to sales ratio | 0.47 | 0.3 | 0.49 | 0.23 | 0.23 | |
POCF ratio | -4.83 | 1.14 | 1.87 | -4.21 | 1.72 | |
PFCF ratio | -4.58 | 1.19 | 2.06 | -4.14 | 1.78 | |
P/B Ratio | 1.04 | 0.63 | 0.48 | 0.37 | 0.22 | |
PTB ratio | 1.04 | 0.63 | 0.48 | 0.37 | 0.22 | |
EV to sales | 1.25 | 0.95 | 1.75 | 1.01 | 1.49 | |
Enterprise value over EBITDA | 11.28 | 9.43 | 14.01 | 192.52 | 15.23 | |
EV to operating cash flow | -12.74 | 3.62 | 6.65 | -18.59 | 10.91 | |
EV to free cash flow | -12.09 | 3.79 | 7.35 | -18.3 | 11.34 | |
Earnings yield | 0.08 | 0.21 | 0.08 | -0.09 | 0.14 | |
Free cash flow yield | -0.22 | 0.84 | 0.48 | -0.24 | 0.56 | |
Debt to equity | 3.15 | 2.47 | 2.08 | 1.76 | 1.61 | |
Debt to assets | 0.2 | 0.19 | 0.18 | 0.17 | 0.17 | |
Net debt to EBITDA | 7 | 6.47 | 10.08 | 148.96 | 12.84 | |
Current ratio | 1.1 | 1.06 | 1.04 | 0.96 | 0.97 | |
Interest coverage | 0 | 0 | 0 | 0 | 0 | |
Income quality | -2.69 | 4.13 | 6.39 | 2.63 | 4.07 | |
Dividend Yield | 0 | 0.1 | 0 | 0 | 0 | |
Payout ratio | 0 | 0.45 | 0 | 0 | 0 | |
Sales general and administrative to revenue | 0.03 | 0.03 | 0.05 | 0.04 | 0.05 | |
Research and developement to revenue | 0 | 0 | 0 | 0 | 0 | |
Intangibles to total assets | 0 | 0 | 0 | 0 | 0 | |
Capex to operating cash flow | 0.05 | -0.04 | -0.1 | 0.02 | -0.04 | |
Capex to revenue | -0.01 | -0.01 | -0.03 | 0 | -0.01 | |
Capex to depreciation | -1.09 | -2.36 | -2.72 | -0.28 | -0.72 | |
Stock based compensation to revenue | 0 | 0 | 0 | 0 | 0 | |
Graham number | 7.89 | 11.85 | 6.59 | 5.96 | 5.43 | |
ROIC | 0.03 | 0.04 | 0.02 | 0 | 0.02 | |
Return on tangible assets | 0.01 | 0.01 | 0 | 0 | 0 | |
Graham Net | -37.33 | -34.22 | -32.15 | -30.36 | -26.76 | |
Working capital | 40.95B | 23.5B | 14.54B | -11.9B | -8.89B | |
Tangible asset value | 87.53B | 96.98B | 97.73B | 92.65B | 92.73B | |
Net current asset value | -46.42B | -49.8B | -54.03B | -64.09B | -64.9B | |
Invested capital | 3.15 | 2.47 | 2.08 | 1.76 | 1.61 | |
Average receivables | 0 | 0 | 0 | 0 | 0 | |
Average payables | 0 | 0 | 0 | 0 | 0 | |
Average inventory | 0 | 0 | 0 | 0 | 0 | |
Days sales outstanding | 95.43 | 77.35 | 142.85 | 75.65 | 124.91 | |
Days payables outstanding | 105.88 | 73.53 | 120.58 | 70.6 | 112.87 | |
Days of inventory on hand | 388.56 | 305.18 | 641.9 | 285.34 | 484.91 | |
Receivables turnover | 0.94 | 1.16 | 0.63 | 1.19 | 0.72 | |
Payables turnover | 0.85 | 1.22 | 0.75 | 1.27 | 0.8 | |
Inventory turnover | 0.23 | 0.29 | 0.14 | 0.32 | 0.19 | |
ROE | 0.08 | 0.13 | 0.04 | -0.03 | 0.03 | |
Capex per share | -0.07 | -0.17 | -0.17 | -0.01 | -0.03 |
1030.HK Frequently Asked Questions
What is Seazen Group Limited stock symbol ?
Seazen Group Limited is a CN stock and trading under the symbol 1030.HK
What is Seazen Group Limited stock quote today ?
Seazen Group Limited stock price is $1.06 today.
Is Seazen Group Limited stock public?
Yes, Seazen Group Limited is a publicly traded company.